Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies

PLoS One. 2012;7(10):e46982. doi: 10.1371/journal.pone.0046982. Epub 2012 Oct 10.

Abstract

Background: Glutathione S-transferase M1 (GSTM1) is thought to be involved in detoxifying several carcinogens and may play a vital role in tumorigenesis. Numerous studies have evaluated the association between GSTM1 null/present polymorphism and risk of prostate cancer (PCa). However, the results remain inconsistent. To derive a more precise estimation, we performed a meta-analysis.

Methodology/principal findings: A comprehensive search was conducted to identify all eligible case-control studies. We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association. The overall association was significant (OR = 1.28, 95% CI: 1.11-1.48, P = 0.001). Moreover, subgroup analyses showed GSTM1 null genotype significantly associated with PCa risk among Asians (OR = 1.35, 95% CI: 1.03-1.78, P = 0.03) but not among Caucasians (OR = 1.12, 95% CI: 0.96-1.31, P = 0.16). In addition, we did not find that smoking modified the genotype effect on the risk of PCa.

Conclusions/significance: The present meta-analysis suggested that GSTM1 null allele was a low-penetrant risk factor for PCa among Asians.

Publication types

  • Meta-Analysis

MeSH terms

  • Alleles
  • Asian People / genetics
  • Case-Control Studies
  • Genetic Predisposition to Disease*
  • Glutathione Transferase / genetics*
  • Humans
  • Male
  • Odds Ratio
  • Polymorphism, Genetic
  • Prostatic Neoplasms / genetics*
  • Smoking / genetics
  • White People / genetics

Substances

  • Glutathione Transferase
  • glutathione S-transferase M1

Grants and funding

No current external funding sources for this study.